NIPPON CHEMIPHAR CO.,LTD. 4539Short Interest

No institution currently reports a short position of 0.5% or more in NIPPON CHEMIPHAR CO.,LTD. (4539). The last disclosure was on 2022-10-11 (Integrated Core Strategies (Asia) Pte. Ltd., 0.49%).

Standard Market(Domestic) Pharmaceutical Pharmaceutical
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
2 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2022-10-07
Latest disclosure2022-10-11 (Integrated Core Strategies (Asia) Pte. Ltd., 0.49%)
Reporting institutions1 firms (2 reports)
Peak estimated short interest0.50% (2022-10-07, 1 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 1 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2022-10-11 Integrated Core Strategies (Asia) Pte. Ltd. Position 21,200 shares Ratio 0.49% ▼0.01% −200 Below 0.5%

Disclosure History 2 in total

Trade date Short seller Position (shares) Ratio Change Note
2022-10-11 Integrated Core Strategies (Asia) Pte. Ltd. Position 21,200 shares Ratio 0.49% ▼0.01% −200 Below 0.5%
2022-10-07 Integrated Core Strategies (Asia) Pte. Ltd. Position 21,400 shares Ratio 0.50% ▲0.10% —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
Eisai Co.,Ltd.4523 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ROHTO PHARMACEUTICAL CO.,LTD.4527 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
ONO PHARMACEUTICAL CO.,LTD.4528 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
SANTEN PHARMACEUTICAL CO.,LTD.4536 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Fuso Pharmaceutical Industries,Ltd.4538 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
TSUMURA & CO.4540 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
KISSEI PHARMACEUTICAL CO.,LTD.4547 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
SEIKAGAKU CORPORATION4548 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
EIKEN CHEMICAL CO.,LTD.4549 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
JCR Pharmaceuticals Co.,Ltd.4552 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1